Jump to content

Teduglutide

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Wouterstomp (talk | contribs) at 14:31, 28 December 2012 (new page). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Teduglutide (brand names Gattex and Revestive) is a glucagon-like peptide-2 analog that is used for the treatment of short bowel syndrome. It works by promoting mucosal growth and possibly restoring gastric emptying and secretion. In Europe it is marketed under the brand Revestive by Nycomed. It was approved by the United States under the name Gattex on December 21, 2012.

Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Teduglutide&oldid=530146560"